SXSW Prize for Technology that Detects Alzheimer Disease

SXSW Prize for Technology that Detects Alzheimer Disease

A coveted honor for innovation was given by SXSW, the South West Festival to the technology capable of diagnosing Alzheimer’s disease before its symptoms appear.on SXSW Prize for Technology

114831_mainimg (1)

Using eye tracking system, Neurotrack, claimed a one hundred percent success rate and clinched the health technologies category as the interactive segment of the festival came to a close.

In the words of Elli Kaplan, the chief executive officer of Richmond, Virginia based Upstart, “It’s a computer based visual cognitive test that is able to diagnose Alzheimer’s disease six years before symptoms appear.”

Kaplan told AFP that, “Today the only way to diagnose Alzheimer’s is once full symptoms are in existence, but that’s years after irreparable damage has already taken place.”


Neurotrack will be initially used by pharmaceuticals manufacturers as it will help them develop drugs to slow down or prevent the most common form of dementia. Progressively it will be provided to doctors and research hospitals and eventually a smart phone and tab application that can be used by individuals.

Kaplan who lost two grandparents to Alzheimer’s said, “Neurotrack was developed in collaboration with Emroy University in Atlanta, Georgia and a crack team of neuroscientists.”

The SXSW Accelerator is a platform that showcases up and coming social, mobile, news, health, entertainment, music and web technologies. Some of the other winners at this festival were mobile advocacy app, Phone2Action; mobile typing assistant, Syntellia; MakieLab, a 3D printing toy and game service; Wanderu, a website for young budget travellers and a social network for maps named Plotter.

About Vinita

Vinita Pariyani is an expert author for the iNewTechnology who has been writing about Smartphone, newest of the tech gadgets, apps and every update that pops up. She is a tech-savvy person who stays on top of cutting-edge technology/ gadgets.